BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34608049)

  • 1. The Added Value of Family Caregivers' Level of Mastery in Predicting Survival of Glioblastoma Patients: A Validation Study.
    Boele FW; Weimer J; Zamanipoor Najafabadi AH; Murray L; Given CW; Given BA; Donovan HS; Drappatz J; Lieberman FS; Sherwood PR
    Cancer Nurs; 2022 Sep-Oct 01; 45(5):363-368. PubMed ID: 34608049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family caregivers' level of mastery predicts survival of patients with glioblastoma: A preliminary report.
    Boele FW; Given CW; Given BA; Donovan HS; Schulz R; Weimer JM; Drappatz J; Lieberman FS; Sherwood PR
    Cancer; 2017 Mar; 123(5):832-840. PubMed ID: 27787881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining care management activities associated with mastery and relationship strain for dementia caregivers.
    Connor KI; McNeese-Smith DK; Vickrey BG; van Servellen GM; Chang BL; Lee ML; Vassar SD; Chodosh J
    J Am Geriatr Soc; 2008 May; 56(5):891-7. PubMed ID: 18384590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing quality of life and mastery of informal caregivers of high-grade glioma patients: a randomized controlled trial.
    Boele FW; Hoeben W; Hilverda K; Lenting J; Calis AL; Sizoo EM; Collette EH; Heimans JJ; Taphoorn MJ; Reijneveld JC; Klein M
    J Neurooncol; 2013 Feb; 111(3):303-11. PubMed ID: 23212677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of caregiver mastery on depressive symptoms.
    Sherwood PR; Given BA; Given CW; Schiffman RF; Murman DL; von Eye A; Lovely M; Rogers LR; Remer S
    J Nurs Scholarsh; 2007; 39(3):249-55. PubMed ID: 17760798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of coping skills intervention with family caregivers of hospice patients with cancer: a randomized clinical trial.
    McMillan SC; Small BJ; Weitzner M; Schonwetter R; Tittle M; Moody L; Haley WE
    Cancer; 2006 Jan; 106(1):214-22. PubMed ID: 16329131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
    Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
    World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution and Predictors of Patient-Caregiver Concordance on States of Life-Sustaining Treatment Preferences over Terminally Ill Cancer Patients' Last Six Months of Life.
    Wen FH; Chou WC; Chen JS; Chang WC; Hsieh CH; Tang ST
    J Palliat Med; 2019 Jan; 22(1):25-33. PubMed ID: 30234418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of deep learning-based survival model in improving survival prediction of patients with glioblastoma.
    Moradmand H; Aghamiri SMR; Ghaderi R; Emami H
    Cancer Med; 2021 Oct; 10(20):7048-7059. PubMed ID: 34453413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparative Analysis of the Usefulness of Survival Prediction Models for Patients with Glioblastoma in the Temozolomide Era: The Importance of Methylguanine Methyltransferase Promoter Methylation, Extent of Resection, and Subventricular Zone Location.
    Woo P; Ho J; Lam S; Ma E; Chan D; Wong WK; Mak C; Lee M; Wong ST; Chan KY; Poon WS
    World Neurosurg; 2018 Jul; 115():e375-e385. PubMed ID: 29678708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Better caregiver mastery is associated with less anxiety in individuals with cognitive impairment.
    Hwang Y; McPhillips MV; Huang L; Perez GA; Hodgson NA
    BMC Nurs; 2023 Sep; 22(1):307. PubMed ID: 37674161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feeling Alone Together: Loneliness in Older Adults with Cognitive Impairment and Their Family Caregivers with Low Mastery.
    Sung P; Chan A; Lim-Soh J
    Dement Geriatr Cogn Disord; 2024; 53(2):66-73. PubMed ID: 38354725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MGMT promoter methylation in patients with glioblastoma: is methylation-sensitive high-resolution melting superior to methylation-sensitive polymerase chain reaction assay?
    Yamashita S; Yokogami K; Matsumoto F; Saito K; Mizuguchi A; Ohta H; Takeshima H
    J Neurosurg; 2018 May; 130(3):780-788. PubMed ID: 29726772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative volumetric assessment of baseline enhancing tumor volume as an imaging biomarker predicts overall survival in patients with glioblastoma.
    Auer TA; Della Seta M; Collettini F; Chapiro J; Zschaeck S; Ghadjar P; Badakhshi H; Florange J; Hamm B; Budach V; Kaul D
    Acta Radiol; 2021 Sep; 62(9):1200-1207. PubMed ID: 32938221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
    Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
    Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The health and well-being of caregivers of children with cerebral palsy.
    Raina P; O'Donnell M; Rosenbaum P; Brehaut J; Walter SD; Russell D; Swinton M; Zhu B; Wood E
    Pediatrics; 2005 Jun; 115(6):e626-36. PubMed ID: 15930188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions to help support caregivers of people with a brain or spinal cord tumour.
    Boele FW; Rooney AG; Bulbeck H; Sherwood P
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012582. PubMed ID: 31264707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual tumor volume and patient survival following reoperation for recurrent glioblastoma.
    Yong RL; Wu T; Mihatov N; Shen MJ; Brown MA; Zaghloul KA; Park GE; Park JK
    J Neurosurg; 2014 Oct; 121(4):802-9. PubMed ID: 25061868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation.
    Molitoris JK; Rao YJ; Patel RA; Kane LT; Badiyan SN; Gittleman H; Barnholtz-Sloan JS; Bentzen SM; Kruser TJ; Huang J; Mehta MP
    J Neurooncol; 2017 Sep; 134(2):331-338. PubMed ID: 28643151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.